Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 3 crawled time : 13:20 save search
GBT Initiates Phase 2/3 Clinical Trial of GBT601 in Patients with Sickle Cell DiseasePhase 2 portion designed to identify the optimal dose for the pivotal Phase 3 portion of the trial
Published: 2022-06-29 (Crawled : 13:20) - biospace.com/
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -0.34%
H: 10.15%
C: 8.54%
gbt601 trial phase 3
Acer Therapeutics Announces Initiation of its Pivotal Phase 3 DiSCOVER Trial of EDSIVO™ (celiprolol) for the Treatment of Vascular Ehlers-Danlos Syndrome
Published: 2022-06-27 (Crawled : 13:20) - biospace.com/
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 1.64%
H: 29.84%
C: 15.32%
treatment trial therapeutics phase 3
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial
Published: 2022-06-27 (Crawled : 13:20) - globenewswire.com
ADIL | $1.9 -12.44% -14.21% 310K
|
Health Technology
|
| O: 9.24%
H: 0.0%
C: -5.38%
trial phase 3
Oncternal Therapeutics Presents Rationale and Plans for its Registrational Phase 3 Study Evaluating Zilovertamab in Combination with Ibrutinib at the EHA 2022 Congress
Published: 2022-06-10 (Crawled : 13:20) - globenewswire.com
ONCT | $8.97 4.3% 4.12% 4.5K
|
Health Technology
|
| O: -5.67%
H: 0.0%
C: 0.0%
therapeutics phase 3
Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study
Published: 2022-05-24 (Crawled : 13:20) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K
|
Health Technology
|
| O: 1.07%
H: 2.65%
C: -7.41%
biotech phase 3
FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
VERU | $1.305 -8.1% -8.81% 2.6M
|
Health Technology
|
| O: 8.28%
H: 2.44%
C: -19.07%
covid-19 fda sabizabulin granted authorization positive phase 3 emergency use authorization
Tarsus Announces Positive Topline Data from Saturn-2 Phase 3, the Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis, and Expects to File a New Drug Application This Year
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
TARS | $32.405 -1.36% -1.37% 630K
|
Health Technology
|
| O: -7.69%
H: 0.47%
C: -17.01%
tp-03 treatment drug topline application trial positive phase 3
Achieve Life Sciences Announces Successful, Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers
Published: 2022-04-27 (Crawled : 13:20) - biospace.com/
ACHV | $4.51 -1.31% -1.33% 35K
|
Health Technology
|
| O: -2.43%
H: 8.03%
C: 2.91%
trial results phase 3
Cidara Therapeutics and Mundipharma to Present Results from Global Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and/or Invasive Candidiasis at ECCMID 2022
Published: 2022-04-14 (Crawled : 13:20) - biospace.com/
CDTX | $0.6855 -5.06% -5.32% 350K
|
Health Technology
|
| O: 0.24%
H: 6.02%
C: 2.49%
treatment trial therapeutics phase 3 candidemia
Aldeyra Therapeutics Announces Completion of Enrollment in Phase 3 TRANQUILITY-2 Trial in Patients with Dry Eye Disease
Published: 2022-04-05 (Crawled : 13:20) - biospace.com/
ALDX | $3.865 -2.89% -2.98% 430K
|
Health Technology
|
| O: 0.0%
H: 2.64%
C: -0.82%
disease eye trial therapeutics enroll phase 3
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.